Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Uterine Cervical Neoplasms × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 8 Liver Neoplasms 4 Carcinoma, Hepatocellular 4 Lung Neoplasms 3 Squamous Intraepithelial Lesions 2 Prostatic Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphatic Metastasis 1 Liver, Cancer of, Non-Resectable 1 Laryngeal Neoplasms 1 Head and Neck Neoplasms 1 HIV Seropositivity 1 Gallbladder Neoplasms 1 Extremities Neoplasms 1 Esophageal Neoplasms 1 Colorectal Liver Metastases 1 Carcinoma, Renal Cell 1 Advanced Intestinal Cancer 1

Interventions

Cisplatin 63 Brachytherapy 29 Radiotherapy 24 Paclitaxel 19 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 19 human papillomavirus vaccine, L1 type 16, 18 18 Topotecan 17 Surveys and Questionnaires 16 Papillomavirus Vaccines 16 Carboplatin 14 Bevacizumab 14 Gemcitabine 12 pembrolizumab 11 Radiation 11 Magnetic Resonance Spectroscopy 11 Colposcopy 11 Methods 10 Early Intervention, Educational 10 Radiotherapy, Intensity-Modulated 9 Papanicolaou Test 9 Vaccines, Synthetic 8 Platinum 8 Ipilimumab 8 Docetaxel 8 Blood Specimen Collection 8 1,2-diaminocyclohexaneplatinum II citrate 8 atezolizumab 7 Vaccines 7 Nivolumab 7 tisotumab vedotin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430610 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡